Clinical Study
Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol
Table 1
Protocol of incremental treatment for ultrarush*, rush§, and slow conventional therapy*.
| Group A | Group B | Group C |
| μg/dose | Cumulative μg/dose | Minute | μg/dose | Cumulative μg/dose | Day | Hour | μg/dose | Cumulative μg/dose | Week | 0.001 | 0.001 | 0 | 0.01 | 0.01 | 1 | 0 | 0.02 | 0.02 | 1 | 0.01 | 0.011 | 15 | 0.1 | 0.11 | | 2 | 0.04 | 0.06 | 2 | 0.04 | 0.051 | 30 | 1 | 1.11 | | 4 | 0.08 | 0.14 | 3 | 0.05 | 0.11 | 45 | 2 | 3.11 | | 6 | 0.2 | 0.34 | 4 | 0.1 | 0.21 | 60 | 3 | 5.11 | 2 | 0 | 0.4 | 0.74 | 5 | 0.4 | 0.61 | 75 | 3.5 | 9.61 | | 2 | 0.8 | 1.54 | 6 | 0.5 | 1.11 | 90 | 3.5 | 13.11 | | 4 | 2 | 3.54 | 7 | 1 | 2.11 | 105 | 10 | 23.11 | 3 | 0 | 4 | 7.54 | 8 | 4 | 6.11 | 120 | 15 | 38.11 | | 2 | 8 | 15.54 | 9 | 5 | 11.11 | 135 | 15 | 53.11 | | 4 | 10 | 25.54 | 10 | 10 | 21.11 | 150 | 20 | 73.11 | 4 | 0 | 20 | 45.54 | 11 | 40 | 61.11 | 165 | 25 | 98.11 | | 2 | 40 | 85.54 | 12 | 50 | 111.101 | 180 | 25 | 123.11 | | 4 | 60 | 145.54 | 13 | | | | 30 | 153.11 | 5 | 0 | 80 | 225.54 | 14 | | | | 35 | 188.11 | | 2 | 100 | 325.54 | 15 | | | | 35 | 223.11 | | 4 | | | |
|
|
*As reported in Patella et al. [22].
§As reported in Bilò et al. [23].
|